Insulet Corporation (PODD)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$165.02+6.56%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · PODD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 34.5% |
| Our one-year growth estimate | diamond | 19.4% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 15.1 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 29 industry peers · Company calendar date is not available
PODD — credit agreement
Dated 2026-09-21
Entry into a Material Definitive Agreement. On September 21, 2026, Insulet Corporation (the “ Company ”) entered into the Ninth Amendment to Credit Agreement (the “ Amendment ”) with the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (the “ Agent ”), amending that certain Credit Agreement, dated as of May 4, 2021 (as previously amended, supplemented or modified, the “ Credit Agreement ”, and as amended by the Amendment, the “ Amended Credit…
Why it matters: EVOLVE is testing a fully closed-loop system for adults with type 2 diabetes. Insulet said the study supports a planned 2027 filing.
Watch forInsulet reports that EVOLVE is enrolling on plan and keeps the planned 2027 filing window.
Also watch forInsulet reports a study delay, an enrollment problem, or a filing plan set for after 2027.
Why it matters: Q3 results test whether Omnipod can keep growing after the full-year outlook was cut. U.S. growth is the key pressure point.
Supportive ifQ3 total Omnipod growth is at least 18% in constant currency, with U.S. growth at least 14%.
Worry ifQ3 total Omnipod growth is below 18% in constant currency, or U.S. growth is below 14%.
Why it matters: Q2 adjusted operating margin rose more than 140 basis points year over year. Q3 results test whether that gain can continue.
Supportive ifQ3 adjusted operating margin grows by about 100 basis points or more from a year earlier.
Worry ifQ3 adjusted operating margin is flat or lower year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$163 on $10,000 · ±1.6% | How much price usually moves either way. |
| Bad day | $419 loss on $10,000 · 4.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,233 loss on $10,000 · 62.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.